Is N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide Safe in Breastfeeding

Question

I am a breastfeeding mother and i want to know if it is safe to use N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide? Is N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide safe for nursing mother and child? Does N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide extracts into breast milk? Does N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide has any long term or short term side effects on infants? Can N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide influence milk supply or can N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide decrease milk supply in lactating mothers?

Answer by DrLact: About N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide usage in lactation

No information is available on the clinical use of N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide during breastfeeding. Because N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide is more than 99% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide therapy and for 2 weeks after the final dose of therapy.

Alternate Drugs

Nivolumab(Unsafe)

Hydroxyurea(Low Risk)

Vinblastine(Dangerous)

Ipilimumab(Unsafe)

Etoposide(Dangerous)

Bleomycin(Dangerous)

Cetuximab(Unsafe)

Doxorubicin(Dangerous)

Vinorelbine(Dangerous)

Imatinib(Unsafe)

Carboplatin(Dangerous)

Moxetumomab Pasudotox

Cyclophosphamide(Dangerous)

Dacarbazine(Dangerous)

Lenvatinib

Tretinoin

Lapatinib

Paclitaxel(Dangerous)

Cisplatin(Unsafe)

Azelaic Acid(Safe)

Dasatinib(Unsafe)

Fluorouracil(Dangerous)

Busulfan(Dangerous)

Docetaxel(Dangerous)

Alemtuzumab(Low Risk)

Dactinomycin(Dangerous)

Rituximab(Low Risk)

Thioguanine(Dangerous)

Nintedanib

Gemcitabine(Dangerous)

Bevacizumab(Low Risk)

Nilotinib(Unsafe)

Pazopanib(Unsafe)

Vincristine(Dangerous)

Tamoxifen(Dangerous)

Erlotinib(Unsafe)

Letrozole(Dangerous)

Mitoxantrone(Dangerous)

Dinutuximab

Midostaurin

Trastuzumab(Unsafe)

Ado-Trastuzumab Emtansine

Exemestane(Dangerous)

Mercaptopurine(Safe)

Cladribine(Dangerous)

Inotuzumab Ozogamicin

Imatinib(Unsafe)

Dasatinib(Unsafe)

Gemcitabine(Dangerous)

Orlistat(Low Risk)

Nilotinib(Unsafe)

Pazopanib(Unsafe)

Allopurinol(Safe)

Erlotinib(Unsafe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Nilotinib(Unsafe)

Pazopanib(Unsafe)

Erlotinib(Unsafe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Nilotinib(Unsafe)

Pazopanib(Unsafe)

Erlotinib(Unsafe)

Dasatinib(Unsafe)

Nilotinib(Unsafe)

Pazopanib(Unsafe)

Erlotinib(Unsafe)

Imatinib(Unsafe)

Synonyms of N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.